Global Lifestyle Archives | Page 153 of 462 | Be Korea-savvy

Archive by category Global Lifestyle

Bright Peak Presents New Data at AACR: BPT567 A First-in-Class Multifunctional PD1-IL18 Immunocytokine

Bright Peak Presents New Data at AACR: BPT567 A First-in-Class Multifunctional PD1-IL18 Immunocytokine

SAN DIEGO and BASEL, Switzerland, April 17 (Korea Bizwire) — Bright Peak Therapeutics, a biotechnology company developing multifunctional precision immunotherapies for cancer and autoimmune disease, today announced the presentation of new data characterizing the highly targeted biological and therapeutic effects of BPT567 that contribute to its potent single agent anti-tumor activity at the American Association [...]

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector

SYDNEY, Australia, April 13 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth panelist session and dinner at AACR. The discussion will focus on collaboration experience with China’s cancer research sector. (Register here) The panelist session is part of the AACR Annual Meeting, April 14 – 19, 2023, [...]

Centro Semillero Offers Two Master’s Programs and Endless Possibilities

Centro Semillero Offers Two Master’s Programs and Endless Possibilities

Houston, Texas, April 13 (Korea Bizwire) — You may have heard the motto, “Those who dare to teach must never cease to learn.” This principle strongly applies to two Houston-area educators who, through Centro Semillero at University of St. Thomas-Houston (UST), have confirmed their callings as teachers and fortified their faith. Moreover, they are applying the academic [...]

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Mont-Saint-Guibert, Belgium, April 13 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on [...]

Biodiversity Should be at the Heart of Global Financial Reform and the IMF Can Lead the Way, Avaaz Shows in Policy Papers

Biodiversity Should be at the Heart of Global Financial Reform and the IMF Can Lead the Way, Avaaz Shows in Policy Papers

WASHINGTON, April 12 (Korea Bizwire) — The International Monetary Fund has a historic opportunity to take immediate measures, undertake institutional reforms, and establish partnerships through which it can finally support the central role of biodiversity in macroeconomic and financial stability, Avaaz said in a policy briefing. Separately, in a 90-page report, Avaaz said that the [...]

Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint

Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint

SHANGHAI, China, April 11 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced that a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“FLAMES Study”, NCT04169997) investigating the poly (ADP-ribose) polymerase (“PARP”) inhibitor, [...]

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Operable NSCLC Patients

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Operable NSCLC Patients

SHANGHAI, China, April 11 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced the acceptance of the supplemental new drug application for toripalimab in combination with chemotherapy as perioperative treatment and toripalimab monotherapy [...]

[INVNT GROUP]™ and MSM Form Strategic Partnership to Enhance Global Marketing Power of Talent and Brands Across Motorsport Industry

[INVNT GROUP]™ and MSM Form Strategic Partnership to Enhance Global Marketing Power of Talent and Brands Across Motorsport Industry

New York, NY, April 11 (Korea Bizwire) — [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT™ and MSM, the global talent and motorsport agency announce a strategic business partnership offering best-in-class marketing and commercial solutions for talent, brands, and events across motorsports, entertainment and beyond. With over 40 years of experience and a proven track record of building [...]

Call for Nominations: 2023 Global Citizen Award®

Call for Nominations: 2023 Global Citizen Award®

LONDON, April 11 (Korea Bizwire) — Leading international residence and citizenship advisory firm Henley & Partners, in partnership with the Swiss non-profit humanitarian Andan Foundation, is pleased to announce the call for nominations for the 2023 Global Citizen Award. Created in 2014, the Global Citizen Award is a tribute that honors remarkable individuals working to advance any one of [...]

From Inner Life to Outer World: How Women, Gen Z Are Invested in Business Education

From Inner Life to Outer World: How Women, Gen Z Are Invested in Business Education

RESTON, Va., April 10 (Korea Bizwire) — People thinking about going back to business schools are more interested in enriching their lives than increasing their incomes, according to a survey of prospective students of graduate management education (GME) released by the Graduate Management Admission Council (GMAC), a global association representing leading business schools. Seventy-nine percent of prospective [...]